Gerald E. Marti

Hematology
217 E Antietam St
Hagerstown, MD 21740

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications

EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma.

EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma.

Journal: Blood
Published: February 27, 2024

The clonal evolution and natural history of MBL.

The clonal evolution and natural history of MBL.

Journal: Blood
Published: October 13, 2022

Genome-wide DNA methylation profiling in chronic lymphocytic leukaemia.

Genome-wide DNA methylation profiling in chronic lymphocytic leukaemia.

Journal: Frontiers in genetics
Published: September 28, 2022

Towards an FDA-cleared basophil activation test.

Towards an FDA-cleared basophil activation test.

Journal: Frontiers in allergy
Published: August 01, 2022

Premonoclonal B-cell lymphocytosis: the CLL cell of origin.

Premonoclonal B-cell lymphocytosis: the CLL cell of origin.

Journal: Blood
Published: October 05, 2021

Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma.

Intensity of antigen expression reflects IGHV mutational status and Dohner-defined prognostic categories in chronic lymphocytic leukemia, monoclonal B-cell lymphocytosis, and small lymphocytic lymphoma.

Journal: Leukemia & lymphoma
Published: March 18, 2021

Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study.

Risk-adapted, ofatumumab-based chemoimmunotherapy and consolidation in treatment-naïve chronic lymphocytic leukemia: a phase 2 study.

Journal: Leukemia & lymphoma
Published: March 03, 2021

Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines.

Effect of Bruton tyrosine kinase inhibitor on efficacy of adjuvanted recombinant hepatitis B and zoster vaccines.

Journal: Blood
Published: August 24, 2020

Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families.

Natural history of monoclonal B-cell lymphocytosis among relatives in CLL families.

Journal: Blood
Published: April 20, 2020

Serum microRNA profiles among dioxin exposed veterans with monoclonal gammopathy of undetermined significance.

Serum microRNA profiles among dioxin exposed veterans with monoclonal gammopathy of undetermined significance.

Journal: Journal of toxicology and environmental health. Part A
Published: April 15, 2020

Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study.

Depth and durability of response to ibrutinib in CLL: 5-year follow-up of a phase 2 study.

Journal: Blood
Published: December 07, 2017

Whole exome sequencing in families with CLL detects a variant in Integrin β 2 associated with disease susceptibility.

Whole exome sequencing in families with CLL detects a variant in Integrin β 2 associated with disease susceptibility.

Journal: Blood
Published: September 16, 2016
Showing 1-12 of 42

Last Updated: 09/26/2026